# DICE Therapeutics, Inc.

DICE Therapeutics, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** DICE Therapeutics, Inc.
- **Former names in filing history:** DiCE Molecules Holdings, LLC (2018-07-25 to 2021-09-10); DiCE MOLECULES HOLDINGS, LLC (2018-07-25 to 2021-09-10)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 30
- **SEC CIK:** 0001645569

## About

DICE Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001645569, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-15, it reported net income of USD -83,887,000; total assets of USD 593,978,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$83.9M (USD -83,887,000)
- **Total assets:** $594.0M (USD 593,978,000)
- **Cash and equivalents:** $461.4M (USD 461,393,000)
- **Operating cash flow:** -$64.3M (USD -64,322,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.1M (USD 1,125,000)
- **Net income:** -$49.0M (USD -48,959,000)
- **Total assets:** $325.8M (USD 325,754,000)
- **Cash and equivalents:** $115.8M (USD 115,826,000)
- **Operating cash flow:** -$39.3M (USD -39,292,000)

## Recent SEC filings

- Form 8-K — filed 2023-08-09 — period 2023-08-09 — 8-K
- Form 10-Q — filed 2023-08-08 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-06-20 — period 2023-06-18 — 8-K
- Form 8-K — filed 2023-06-07 — period 2023-06-07 — 8-K
- Form 8-K — filed 2023-05-11 — period 2023-05-11 — 8-K
- Form 10-Q — filed 2023-05-11 — period 2023-03-31 — 10-Q
- Form DEF 14A — filed 2023-04-26 — period 2023-06-07 — DEF 14A
- Form 8-K — filed 2023-03-15 — period 2023-03-15 — 8-K
- Form 10-K — filed 2023-03-15 — period 2022-12-31 — 10-K
- Form SC 13G — filed 2023-02-14
- Form SC 13G — filed 2023-02-14 — DICE THERAPEUTICS, INC.
- Form SC 13G — filed 2023-02-13

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/dice-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology